Augmenting outcomes in patients with advanced heart failure

Affiliations

Editorial

G Michael Felker. Eur Heart J. 2015.

. 2015 Sep 7;36(34):2276-8.

doi: 10.1093/eurheartj/ehv283. Epub 2015 Jun 20.

¹ Division of Cardiology, Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, USA michael.felker@duke.edu.

No abstract available

Comment on

A prospective comparison of alginate-hydrogel with standard medical therapy to determine impact on functional capacity and clinical outcomes in patients with advanced heart failure (AUGMENT-HF trial).
Anker SD, Coats AJ, Cristian G, Dragomir D, Pusineri E, Piredda M, Bettari L, Dowling R, Volterrani M, Kirwan BA, Filippatos G, Mas JL, Danchin N, Solomon SD, Lee RJ, Ahmann F, Hinson A, Sabbah HN, Mann DL. Anker SD, et al. Eur Heart J. 2015 Sep 7;36(34):2297-309. doi: 10.1093/eurheartj/ehv259. Epub 2015 Jun 16. Eur Heart J. 2015. PMID: 26082085 Free PMC article. Clinical Trial.